LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $225,838 | -69.5% | 3,769 | -62.6% | 0.00% | -100.0% |
| Q1 2023 | $741,338 | -5.3% | 10,078 | -14.0% | 0.01% | -21.4% |
| Q4 2022 | $782,696 | +118.0% | 11,717 | +181.3% | 0.01% | +100.0% |
| Q3 2022 | $359,000 | -16.3% | 4,166 | -13.4% | 0.01% | -41.7% |
| Q2 2022 | $429,000 | -66.8% | 4,811 | -63.0% | 0.01% | -84.4% |
| Q3 2019 | $1,294,000 | -32.1% | 13,000 | -22.2% | 0.08% | -63.2% |
| Q2 2019 | $1,906,000 | – | 16,700 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |